{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:03:00Z","timestamp":1793329380479,"version":"4.5.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T00:00:00Z","timestamp":1761523200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02922-2","type":"journal-article","created":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T13:09:02Z","timestamp":1761570542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Drug-coated balloons and diabetes: a review"],"prefix":"10.1186","volume":"24","author":[{"given":"Marco","family":"Frazzetto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Malakouti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharat","family":"Khialani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo Luca","family":"Gurgoglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"2922_CR1","first-page":"439","volume":"32","author":"D Aronson","year":"2014","unstructured":"Aronson D, Edelman ER. Coronary artery disease and diabetes mellitus. Cardiol Clin. 2014;32:439\u201355.","journal-title":"Cardiol Clin"},{"key":"2922_CR2","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12933-022-01637-y","volume":"21","author":"RA Montone","year":"2022","unstructured":"Montone RA, Pitocco D, Gurgoglione FL, Rinaldi R, Del Buono MG, Camilli M, Rizzi A, Tartaglione L, Rizzo GE, Di Leo M, Flex A, Russo M, Liuzzo G, Magnani G, Bonadonna RC, Ardissino D, Crea F, Niccoli G. Microvascular complications identify a specific coronary atherosclerotic phenotype in patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2022;21:211.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR3","doi-asserted-by":"publisher","first-page":"e0208746","DOI":"10.1371\/journal.pone.0208746","volume":"13","author":"Y Yang","year":"2018","unstructured":"Yang Y, Park G-M, Han S, Kim Y-G, Suh J, Park HW, Won K-B, Ann SH, Kim S-J, Kim D-W, Park M-W, Her SH, Lee S-G. Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: results from a Korean nationwide study. PLoS ONE. 2018;13:e0208746.","journal-title":"PLoS ONE"},{"key":"2922_CR4","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1016\/S0735-1097(98)00467-7","volume":"32","author":"S Elezi","year":"1998","unstructured":"Elezi S, Kastrati A, Pache J, Wehinger A, Hadamitzky M, Dirschinger J, Neumann FJ, Sch\u00f6mig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J Am Coll Cardiol. 1998;32:1866\u201373.","journal-title":"J Am Coll Cardiol"},{"key":"2922_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S2213-8587(13)70114-1","volume":"1","author":"AP Kappetein","year":"2013","unstructured":"Kappetein AP, Head SJ. CABG or PCI for revascularisation in patients with diabetes? Lancet Diabetes Endocrinol. 2013;1:266\u20138.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2922_CR6","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/CIRCULATIONAHA.111.031070","volume":"124","author":"GW Stone","year":"2011","unstructured":"Stone GW, Kedhi E, Kereiakes DJ, Parise H, Fahy M, Serruys PW, Smits PC. Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus. Circulation. 2011;124:893\u2013900.","journal-title":"Circulation"},{"key":"2922_CR7","doi-asserted-by":"publisher","first-page":"e5170","DOI":"10.1136\/bmj.e5170","volume":"345","author":"S Bangalore","year":"2012","unstructured":"Bangalore S, Kumar S, Fusaro M, Amoroso N, Kirtane AJ, Byrne RA, Williams DO, Slater J, Cutlip DE, Feit F. Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials. BMJ. 2012;345:e5170.","journal-title":"BMJ"},{"key":"2922_CR8","doi-asserted-by":"publisher","first-page":"e003255","DOI":"10.1161\/CIRCINTERVENTIONS.115.003255","volume":"9","author":"KC Koskinas","year":"2016","unstructured":"Koskinas KC, Siontis GCM, Piccolo R, Franzone A, Haynes A, Rat-Wirtzler J, Silber S, Serruys PW, Pilgrim T, R\u00e4ber L, Heg D, J\u00fcni P, Windecker S. Impact of diabetic status on outcomes after revascularization with drug-eluting stents in relation to coronary artery disease complexity: patient-level pooled analysis of 6081 patients. Circ Cardiovasc Interv. 2016;9:e003255.","journal-title":"Circ Cardiovasc Interv"},{"key":"2922_CR9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.carrev.2019.03.001","volume":"21","author":"M Megaly","year":"2020","unstructured":"Megaly M, Ali A, Abraham B, Khalil C, Zordok M, Shaker M, Tawadros M, Hennawy BS, Elbadawi A, Omer M, Saad M. Outcomes with drug-coated balloons in percutaneous coronary intervention in diabetic patients. Cardiovasc Revasc Med. 2020;21:78\u201385.","journal-title":"Cardiovasc Revasc Med"},{"key":"2922_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","volume":"17","author":"TR Einarson","year":"2018","unstructured":"Einarson TR, Acs A, Ludwig C, Panton UH. Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007\u20132017. Cardiovasc Diabetol. 2018;17:83.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2840-1-1","volume":"1","author":"D Aronson","year":"2002","unstructured":"Aronson D, Rayfield EJ. How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc Diabetol. 2002;1:1.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00019501-199711000-00002","volume":"8","author":"M Chaour","year":"1997","unstructured":"Chaour M, Th\u00e9roux P, Gilfix BM, Campeau L, Lesp\u00e9rance J, Ghitescu M, G\u00e9linas F, Solymoss BC. True fasting serum insulin level, insulin resistance syndrome and coronary artery disease. Coron Artery Dis. 1997;8:683\u20138.","journal-title":"Coron Artery Dis"},{"key":"2922_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","volume":"11","author":"CE Tabit","year":"2010","unstructured":"Tabit CE, Chung WB, Hamburg NM, Vita JA. Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications. Rev Endocr Metab Disord. 2010;11:61\u201374.","journal-title":"Rev Endocr Metab Disord"},{"key":"2922_CR14","doi-asserted-by":"publisher","first-page":"2444","DOI":"10.1093\/eurheartj\/eht142","volume":"34","author":"JA Beckman","year":"2013","unstructured":"Beckman JA, Paneni F, Cosentino F, Creager MA. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444\u201352.","journal-title":"Eur Heart J"},{"key":"2922_CR15","doi-asserted-by":"publisher","first-page":"e028985","DOI":"10.1161\/JAHA.122.028985","volume":"12","author":"Z Ke","year":"2023","unstructured":"Ke Z, Huang R, Xu X, Liu W, Wang S, Zhang X, Guo Y, Zhuang X, Zhen L. Long-term high level of insulin resistance is associated with an increased prevalence of coronary artery calcification: the CARDIA study. J Am Heart Assoc. 2023;12:e028985.","journal-title":"J Am Heart Assoc"},{"key":"2922_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1161\/01.CIR.57.1.133","volume":"57","author":"AC Dortimer","year":"1978","unstructured":"Dortimer AC, Shenoy PN, Shiroff RA, Leaman DM, Babb JD, Liedtke AJ, Zelis R. Diffuse coronary artery disease in diabetic patients: Fact or fiction? Circulation. 1978;57:133\u20136.","journal-title":"Circulation"},{"key":"2922_CR17","doi-asserted-by":"publisher","first-page":"e009245","DOI":"10.1161\/JAHA.118.009245","volume":"7","author":"T Sugiyama","year":"2018","unstructured":"Sugiyama T, Yamamoto E, Bryniarski K, Xing L, Fracassi F, Lee H, Jang I-K. Coronary plaque characteristics in patients with diabetes mellitus who presented with acute coronary syndromes. J Am Heart Assoc. 2018;7:e009245.","journal-title":"J Am Heart Assoc"},{"key":"2922_CR18","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.1093\/eurheartj\/ehab433","volume":"42","author":"E Kedhi","year":"2021","unstructured":"Kedhi E, Berta B, Roleder T, Hermanides RS, Fabris E, IJsselmuiden AJJ, Kauer F, Alfonso F, von Birgelen C, Escaned J, Camaro C, Kennedy MW, Pereira B, Magro M, Nef H, Reith S, Al Nooryani A, Rivero F, Malinowski K, De Luca G, Garcia Garcia H, Granada JF, Wojakowski W. Thin-cap fibroatheroma predicts clinical events in diabetic\u2002patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Eur Heart J. 2021;42:4671\u20139.","journal-title":"Eur Heart J"},{"key":"2922_CR19","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1016\/j.jcin.2018.09.033","volume":"11","author":"M Konigstein","year":"2018","unstructured":"Konigstein M, Ben-Yehuda O, Smits PC, Love MP, Banai S, Perlman GY, Golomb M, Ozan MO, Liu M, Leon MB, Stone GW, Kandzari DE. Outcomes among diabetic patients undergoing percutaneous coronary intervention with contemporary drug-eluting stents: analysis from the BIONICS randomized trial. JACC Cardiovasc Interv. 2018;11:2467\u201376.","journal-title":"JACC Cardiovasc Interv"},{"key":"2922_CR20","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12933-020-01173-7","volume":"19","author":"T Ishihara","year":"2020","unstructured":"Ishihara T, Sotomi Y, Tsujimura T, Iida O, Kobayashi T, Hamanaka Y, Omatsu T, Sakata Y, Higuchi Y, Mano T. Impact of diabetes mellitus on the early-phase arterial healing after drug-eluting stent implantation. Cardiovasc Diabetol. 2020;19:203.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12933-021-01405-4","volume":"20","author":"EH Ploumen","year":"2021","unstructured":"Ploumen EH, Pinxterhuis TH, Zocca P, Roguin A, Anthonio RL, Schotborgh CE, Benit E, Aminian A, Danse PW, Doggen CJM, von Birgelen C, Kok MM. Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials. Cardiovasc Diabetol. 2021;20:217.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR22","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s12933-024-02201-6","volume":"23","author":"X Sun","year":"2024","unstructured":"Sun X, Zhang C, Ma Y, He Y, Zhang X, Wu J. Association between diabetes mellitus and primary restenosis following endovascular treatment: a comprehensive meta-analysis of randomized controlled trials. Cardiovasc Diabetol. 2024;23:132.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR23","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.4244\/EIJ-D-21-00636","volume":"18","author":"T Kawai","year":"2022","unstructured":"Kawai T, Watanabe T, Yamada T, Morita T, Furukawa Y, Tamaki S, Kawasaki M, Kikuchi A, Seo M, Nakamura J, Tachibana K, Kida H, Sotomi Y, Sakata Y, Fukunami M. Coronary vasomotion after treatment with drug-coated balloons or drug-eluting stents: a prospective, open-label, single-centre randomised trial. EuroIntervention. 2022;18:e140\u20138.","journal-title":"EuroIntervention"},{"key":"2922_CR24","first-page":"194","volume":"12","author":"ZMF Shahrori","year":"2025","unstructured":"Shahrori ZMF, Frazzetto M, Mahmud SH, Alghwyeen W, Cortese B. Drug-Coated balloons: recent evidence and upcoming novelties. J Cardiovasc Dev Dis. 2025;12:194.","journal-title":"J Cardiovasc Dev Dis"},{"key":"2922_CR25","first-page":"1423","volume":"104","author":"M Verdoia","year":"2024","unstructured":"Verdoia M, Nardin M, Rognoni A, Cortese B. Drug-coated balloons in high-risk patients and diabetes mellitus: a meta-analysis of 10 studies. Catheter Cardiovasc Interv. 2024;104:1423\u201333.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2922_CR26","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jcin.2016.03.037","volume":"9","author":"F Alfonso","year":"2016","unstructured":"Alfonso F, P\u00e9rez-Vizcayno MJ, Garc\u00eda D, Blanco B, Otaegui I, Masotti M, Zueco J, Vel\u00e1quez M, Sanch\u00eds J, Garc\u00eda-Touchard A, L\u00e1zaro-Garc\u00eda R, Moreu J, Bethencourt A, Cuesta J, Rivero F, C\u00e1rdenas A, Gonzalo N, Jim\u00e9nez-Quevedo P, Fern\u00e1ndez C, RIBS V Study Investigators. Long-term results of everolimus-eluting stents versus drug-eluting balloons in patients with bare-metal in-stent restenosis: 3-year follow-up of the RIBS V clinical trial. JACC Cardiovasc Interv. 2016;9:1246\u201355.","journal-title":"JACC Cardiovasc Interv"},{"key":"2922_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","volume":"11","author":"J Baan","year":"2018","unstructured":"Baan J, Claessen BE, Dijk KB, Vendrik J, van der Schaaf RJ, Meuwissen M, van Royen N, Gosselink ATM, van Wely MH, Dirkali A, Arkenbout EK, de Winter RJ, Koch KT, Sjauw KD, Beijk MA, Vis MM, Wykrzykowska JJ, Piek JJ, Tijssen JGP, Henriques JPS. A randomized comparison of Paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial. JACC Cardiovasc Interv. 2018;11:275\u201383.","journal-title":"JACC Cardiovasc Interv"},{"key":"2922_CR28","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/eurheartj\/ehad026","volume":"44","author":"D Giacoppo","year":"2023","unstructured":"Giacoppo D, Alvarez-Covarrubias HA, Koch T, Cassese S, Xhepa E, Kessler T, Wiebe J, Joner M, Hochholzer W, Laugwitz K-L, Schunkert H, Kastrati A, Kufner S. Coronary artery restenosis treatment with plain balloon, drug-coated balloon, or drug-eluting stent: 10-year outcomes of the ISAR-DESIRE 3 trial. Eur Heart J. 2023;44:1343\u201357.","journal-title":"Eur Heart J"},{"key":"2922_CR29","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"C Vrints","year":"2024","unstructured":"Vrints C, Andreotti F, Koskinas KC, Rossello X, Adamo M, Ainslie J, Banning AP, Budaj A, Buechel RR, Chiariello GA, Chieffo A, Christodorescu RM, Deaton C, Doenst T, Jones HW, Kunadian V, Mehilli J, Milojevic M, Piek JJ, Pugliese F, Rubboli A, Semb AG, Senior R, Ten Berg JM, Van Belle E, Van Craenenbroeck EM, Vidal-Perez R, Winther S, ESC Scientific Document Group. 2024 ESC guidelines for the management of chronic coronary syndromes. Eur Heart J. 2024;45:3415\u2013537.","journal-title":"Eur Heart J"},{"key":"2922_CR30","first-page":"216","volume":"93","author":"BE Claessen","year":"2019","unstructured":"Claessen BE, Henriques JPS, Vendrik J, Boerlage-van Dijk K, van der Schaaf RJ, Meuwissen M, van Royen N, Gosselink ATM, van Wely MH, Dirkali A, Arkenbout EK, Piek JJ, Baan J. Paclitaxel-eluting balloon versus everolimus-eluting stent in patients with diabetes mellitus and in-stent restenosis: insights from the randomized DARE trial. Catheter Cardiovasc Interv. 2019;93:216\u201321.","journal-title":"Catheter Cardiovasc Interv"},{"key":"2922_CR31","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.3390\/jcm13154464","volume":"13","author":"P Niezgoda","year":"2024","unstructured":"Niezgoda P, Kasprzak M, Kubica J, Ku\u017ama \u0141, Januszek R, Iwa\u0144czyk S, Tomasiewicz B, Bil J, Kowalewski M, Jaguszewski M, Wybraniec M, Reczuch K, Dobrzycki S, Bartu\u015b S, Lesiak M, G\u0105sior M, Wolny R, Witkowski A, Gil R, Cortese B, D\u2019Ascenzo F, Wojakowski W, Wa\u0144ha W. Drug-eluting balloons and drug-eluting stents in diabetic patients undergoing percutaneous coronary intervention due to Restenosis-DM-Dragon registry. J Clin Med. 2024;13:4464.","journal-title":"J Clin Med"},{"key":"2922_CR32","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.pcad.2024.12.003","volume":"88","author":"A Gupta","year":"2025","unstructured":"Gupta A, Maitas O, Patel RAG. Recurrent drug eluting stent, in-stent restenosis (DES-ISR): epidemiology, pathophysiology & treatment. Prog Cardiovasc Dis. 2025;88:68\u201374.","journal-title":"Prog Cardiovasc Dis"},{"key":"2922_CR33","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.carrev.2016.12.008","volume":"18","author":"F Giannini","year":"2017","unstructured":"Giannini F, Latib A, Jabbour RJ, Costopoulos C, Chieffo A, Carlino M, Montorfano M, Menozzi A, Castriota F, Micari A, Cremonesi A, De Felice F, Marchese A, Tespili M, Presbitero P, Sgueglia GA, Buffoli F, Tamburino C, Varbella F, Colombo A. Comparison of Paclitaxel drug-eluting balloon and Paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial. Cardiovasc Revasc Med. 2017;18:4\u20139.","journal-title":"Cardiovasc Revasc Med"},{"key":"2922_CR34","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","volume":"396","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow M-A, Mangner N, M\u00f6bius-Winkler S, Weilenmann D, W\u00f6hrle J, Stachel G, Markovic S, Leibundgut G, Rickenbacher P, Osswald S, Cattaneo M, Gilgen N, Kaiser C, Scheller B. BASKET-SMALL 2 investigators. Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet. 2020;396:1504\u201310.","journal-title":"Lancet"},{"key":"2922_CR35","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/j.jcin.2021.06.025","volume":"14","author":"J W\u00f6hrle","year":"2021","unstructured":"W\u00f6hrle J, Scheller B, Seeger J, Farah A, Ohlow M-A, Mangner N, M\u00f6bius-Winkler S, Weilenmann D, Stachel G, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Jeger RV. BASKET-SMALL 2 investigators. Impact of diabetes on outcome with drug-coated balloons versus drug-eluting stents: the BASKET-SMALL 2 trial. JACC Cardiovasc Interv. 2021;14:1789\u201398.","journal-title":"JACC Cardiovasc Interv"},{"key":"2922_CR36","first-page":"119","volume":"10","author":"J Seeger","year":"2023","unstructured":"Seeger J, W\u00f6hrle J, Scheller B, Farah A, Ohlow M-A, Mangner N, M\u00f6bius-Winkler S, Weilenmann D, Stachel G, Leibundgut G, Rickenbacher P, Cattaneo M, Gilgen N, Kaiser C, Jeger R, On Behalf Of The Basket-Small Investigators null. Impact of insulin-treated compared to non-insulin-treated diabetes mellitus on outcome of percutaneous coronary intervention with drug-coated balloons versus drug-eluting stents in de Novo coronary artery disease: the randomized BASKET-SMALL 2 trial. J Cardiovasc Dev Dis. 2023;10:119.","journal-title":"J Cardiovasc Dev Dis"},{"key":"2922_CR37","doi-asserted-by":"publisher","first-page":"1036766","DOI":"10.3389\/fpubh.2022.1036766","volume":"10","author":"K Li","year":"2022","unstructured":"Li K, Cui K, Dan X, Feng J, Pu X. The comparative short-term efficacy and safety of drug-coated balloon vs. drug-eluting stent for treating small-vessel coronary artery lesions in diabetic patients. Front Public Health. 2022;10:1036766.","journal-title":"Front Public Health"},{"key":"2922_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12933-023-01853-0","volume":"22","author":"A-Y Her","year":"2023","unstructured":"Her A-Y, Shin E-S, Kim S, Kim B, Kim T-H, Sohn C-B, Choi BJ, Park Y, Cho JR, Jeong Y-H. Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease. Cardiovasc Diabetol. 2023;22:120.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.amjcard.2023.08.113","volume":"206","author":"M Verdoia","year":"2023","unstructured":"Verdoia M, Zilio F, Gioscia R, Viola O, Brancati MF, Fanti D, Sold\u00e0 PL, Bonmassari R, Rognoni A, De Luca G. Prognostic impact of drug-coated balloons in patients with diabetes mellitus: a propensity-matched study. Am J Cardiol. 2023;206:73\u20138.","journal-title":"Am J Cardiol"},{"key":"2922_CR40","doi-asserted-by":"publisher","first-page":"935263","DOI":"10.3389\/fcvm.2022.935263","volume":"9","author":"X Yang","year":"2022","unstructured":"Yang X, Lu W, Pan L, Han Z, Pan S, Wang X, Zhu Y, Shan Y, Peng M, Qin P, Zhang P, Qin X, Sun G, Qin Z, Dong J, Qiu C. Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions. Front Cardiovasc Med. 2022;9:935263.","journal-title":"Front Cardiovasc Med"},{"key":"2922_CR41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.23736\/S2724-5683.23.06352-4","volume":"72","author":"A Buono","year":"2024","unstructured":"Buono A, Pellicano M, Regazzoli D, Donahue M, Tedeschi D, Loffi M, Zimbardo G, Reimers B, Danzi G, DE Blasio G, Tespili M, Ielasi A. Procedural and one-year outcomes following drug-eluting stent and drug-coated balloon combination for the treatment of de Novo diffuse coronary artery disease: the HYPER study. Minerva Cardiol Angiol. 2024;72:163\u201371.","journal-title":"Minerva Cardiol Angiol"},{"key":"2922_CR42","doi-asserted-by":"publisher","first-page":"5495219","DOI":"10.1155\/2021\/5495219","volume":"2021","author":"L Pan","year":"2021","unstructured":"Pan L, Lu W, Han Z, Pan S, Wang X, Shan Y, Wang X, Zheng X, Li R, Zhou Y, Qin P, Shi Q, Zhou S, Zhang W, Guo S, Zhang P, Qin X, Sun G, Qin Z, Huang Z, Qiu C. Clinical outcomes of Drug-Coated balloon in coronary patients with and without diabetes mellitus: a multicenter, propensity score study. J Diabetes Res. 2021;2021:5495219.","journal-title":"J Diabetes Res"},{"key":"2922_CR43","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-024-02139-9","volume":"23","author":"G Caiazzo","year":"2024","unstructured":"Caiazzo G, Oliva A, Testa L, Heang TM, Lee CY, Milazzo D, Stefanini G, Pesenti N, Mangieri A, Colombo A, Cortese B. EASTBOURNE investigators. Sirolimus-coated balloon in all-comer population of coronary artery disease patients: the EASTBOURNE DIABETES prospective registry. Cardiovasc Diabetol. 2024;23:52.","journal-title":"Cardiovasc Diabetol"},{"key":"2922_CR44","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.jcin.2023.05.005","volume":"16","author":"B Cortese","year":"2023","unstructured":"Cortese B, Testa L, Heang TM, Ielasi A, Bossi I, Latini RA, Lee CY, Perez IS, Milazzo D, Caiazzo G, Tomai F, Benincasa S, Nuruddin AA, Stefanini G, Buccheri D, Seresini G, Singh R, Karavolias G, Cacucci M, Sciahbasi A, Ocaranza R, Menown IBA, Torres A, Sengottvelu G, Zanetti A, Pesenti N, Colombo A, EASTBOURNE Investigators. Sirolimus-Coated balloon in an all-comer population of coronary artery disease patients: the EASTBOURNE prospective registry. JACC Cardiovasc Interv. 2023;16:1794\u2013803.","journal-title":"JACC Cardiovasc Interv"},{"key":"2922_CR45","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","volume":"6","author":"E Ahlqvist","year":"2018","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P, Wessman Y, Shaat N, Sp\u00e9gel P, Mulder H, Lindholm E, Melander O, Hansson O, Malmqvist U, Lernmark \u00c5, Lahti K, Fors\u00e9n T, Tuomi T, Rosengren AH, Groop L. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6:361\u20139.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2922_CR46","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1161\/CIRCULATIONAHA.124.071689","volume":"150","author":"BL Neuen","year":"2024","unstructured":"Neuen BL, Fletcher RA, Heath L, Perkovic A, Vaduganathan M, Badve SV, Tuttle KR, Pratley R, Gerstein HC, Perkovic V, Heerspink HJL. Cardiovascular, kidney, and safety outcomes with GLP-1 receptor agonists alone and in combination with SGLT2 inhibitors in type 2 diabetes: a systematic review and Meta-Analysis. Circulation. 2024;150:1781\u201390.","journal-title":"Circulation"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02922-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02922-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T11:10:45Z","timestamp":1761909045000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02922-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2922"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02922-2","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"408"}}